Priorities for research on tropical viruses after the 2014 Ebola epidemic

Journal of Clinical Virology

Volumn 64, Issue , 2015, Pages 107-108

  ter Meulen, J ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Hemorrhagic fever viruses; Research; Review

Indexed keywords

EBOLA VACCINE;

CHIKUNGUNYA ALPHAVIRUS; CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS; DENGUE VIRUS; EBOLA HEMORRHAGIC FEVER; EDITORIAL; EPIDEMIC; FILOVIRUS; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH; RURAL AREA; TROPICS; VIRUS; YELLOW FEVER FLAVIVIRUS; HEMORRHAGIC FEVER, EBOLA; MEDICAL RESEARCH; VIRUS INFECTION;

BIOMEDICAL RESEARCH; EPIDEMICS; HEMORRHAGIC FEVER, EBOLA; HUMANS; VIRUS DISEASES;

EID: 84923563528     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.12.008     Document Type: Editorial

References (4)

1. Cohen J. Infectious disease. Ebola vaccines racing forward at record pace. Science 2014, 345:1228-1229.
2. Butler D. Ebola drug trials set to begin amid crisis. Nature 2014, 513:13-14.
3. Cohen J., Kupferschmidt K. Infectious diseases. Ebola vaccine trials raise ethical issues. Science 2014, 346:289-290.
4. Morse S.S., Mazet J.A., Woolhouse M., Parrish C.R., Carroll D., Karesh W.B., et al. Prediction and prevention of the next pandemic zoonosis. Lancet 2012, 380:1956-1965.